Commentary on "Cognitive Impairment Associated with Toxigenic Fungal Exposure"

Applied Neuropsychology

Volumn 12, Issue 3, 2005, Pages 129-133

  Fox, David D ^a   Greiffenstein, M Frank ^b   Lees Haley, Paul R ^a  

^a Psychological Systems Inc ^*  (United States)

^b Psychological Systems Inc   (United States)

Author keywords

Cognitive impairment; Mycotoxins; Neuropsychological; Toxic mold

Indexed keywords

MYCOTOXIN;

ANALYTICAL ERROR; BRAIN INJURY; COGNITIVE DEFECT; DATA ANALYSIS; DISEASE ASSOCIATION; HEAD INJURY; HISTORY OF MEDICINE; HUMAN; METHODOLOGY; MOULD; MYCOSIS; RELIABILITY; REVIEW; STATISTICAL ANALYSIS;

EID: 24944569294     PISSN: 09084282     EISSN: 15324826     Source Type: Journal    
DOI: 10.1207/S15324826AN1203_1     Document Type: Review

References (13)

1. Brown, A. P., O'Brien, D., & Adams, D. H. (1991). Ten year review of invasive aspergillosis detected at necropsy. Journal of Clinical Pathology, 44, 452-454.
2. Committee on Damp Spaces and Health, Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies. (2004). Damp indoor spaces and health. Washington, DC: National Academies Press.
3. Fox, D. D., Lees-Haley, P. R., Earnest, K., & Dolezal-Wood, S. (1995a). Base rates of post-concussive symptoms in HMO patients and controls. Neuropsychology, 9, 606-611.
4. Fox, D. D., Lees-Haley, P. R., Earnest, K., & Dolezal-Wood, S. (1995b). Post-concussive symptoms: Base rates and etiology in psychiatric patients. The Clinical Neuropsychologist, 9, 89-92.
5. Gordon, W. A., Cantor, J. B., Johanning, E., Charatz, H. J., Ashman, T. A., Breeze, J. L., et al. (2004). Cognitive impairment associated with toxigenic fungal exposure: A replication and extension of previous findings. Applied Neuropsychology, 11, 65-74.
6. Hardin, B. D., Kelman, B. J., & Saxon, A. (2002, October 27). ACOEM evidence-based statement: Adverse human health effects associated with molds in the indoor environment. American College of Occupational and Environmental Medicine. Retrieved October 8, 2003 from http://www.acoem.org/guidelines/ article.asp?ID=52
7. Hawkins, K. A., & Tulsky, D. S. (2003). WAIS-III WMS-III discrepancy analysis: Six factor model index discrepancy base rates, implications, and a preliminary consideration of utility. In D. S. Tulsky, D. H. Saklofske, G. Chelune, R. K. Heaton, R. J. Ivnik, R. Bornstein, et al. (Eds.), Clinical interpretation of the WAIS-III and WMS-III (pp. 211-214). San Diego, CA: Academic.
8. Hill, A. B. (1965). The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, 58, 295-300.
9. Hodgson, M. J., Morey, P., Leung, W., Morrow, L., Miller, D., Jarvis, B. B., et al. (1998). Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. Journal of Occupational and Environmental Medicine, 40, 241-248.
10. Larrabee, G. J. (2003). Detection of malingering using atypical performance patterns on standard neuropsychological tests. Clinical Neuropsychologist, 17, 410-425.
11. Lees-Haley, P. R., Fox, D. D., & Courtney, J. C. (2001). A comparison of complaints by mild brain injury claimants and other claimants describing subjective experiences immediately following their injury. Archives of Clinical Neuropsychology, 16, 689-695.
12. Mittenberg, W., Patton, C., Canyock, E. M., & Condit, D. C. (2002). Base rates of malingering and symptom exaggeration. Journal of Clinical & Experimental Neuropsychology, 24, 1094-1102.
13. van Hout, M. S., Schmand, B., Wekking, E. M., Hageman, G., & Deelman, B. G. (2003). Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy. Neurotoxicology, 24, 547-551.